Rationale for growth hormone therapy in children with chronic kidney disease.
Growth retardation is a common complication in children with chronic kidney disease. Treatable causes of growth retardation in these patients include renal osteodystrophy, metabolic acidosis, and inadequate nutritional intake. In addition, disturbances in the growth hormone-insulinlike growth factor I axis are a major cause of decreased growth. Administration of recombinant human growth hormone can overcome this problem, allowing catch-up growth and achievement of normal or improved adult height.
Greenbaum
Larry A
LA
Medical College of Wisconsin, Department of Pediatrics, 8701 Watertown Plank Rd, Milwaukee, WI 53226, USA. Lgreen@mcw.edu
Del Rio
Marcela
M
Bamgbola
Fatai
F
Kaskel
Frederick
F
D000293:Adolescent; D000818:Animals; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology*; D013006:Growth Hormone / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D007674:Kidney Diseases / Q000150:complications*
D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone